Conditions: Venous Thromboembolism
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 9
Healthy volunteers: no

Brief summary:
To investigate the safety and tolerability of dabigatran etexilate capsules in a small group of eight adolescent patients.

Detailed description:

Arms:
arm 1: open label; patient to receive dabigatran etexilate BID for three days

Interventions: intervention 1: dabigatran etexilate
Intervention descriptions: intervention 1: 2.14 mg/kg BID to a max 150 mg BID

Protocol document: